CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.15%Below 5Y avg (3.00%)
Annual Rate
CNY 0.30Paid annual
Payout Ratio
76.9%Moderate
Payback Period
49.4 yr
Last Ex-Dividend
May 29, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.23BCNY332.34M · vs all stocks (USD)
Trailing P/E
35.69xRevenue (TTM)
267.01MCNY39.84M · vs all stocks (USD)
Profit Margin
23.23%Beta
0.3140xvs all stocks
52-Week Change
-11.22%vs all stocks
Market Capitalization
2.23BCNY332.34M · vs all stocks (USD)
Enterprise Value
1.50BCNY223.11M · vs all stocks (USD)
Trailing P/E
35.69xPrice to Sales (TTM)
8.34xPrice to Book (MRQ)
2.69xEnterprise to Revenue
5.60xEnterprise to EBITDA
19.38xGross Margin
47.21%Profit Margin
23.23%Operating Margin
21.29%Return on Assets (TTM)
4.48%Return on Equity (TTM)
7.55%Revenue (TTM)
267.01MCNY39.84M · vs all stocks (USD)
Revenue per Share (TTM)
1.68CNYUpdated Sep 20, 2026Quarterly Revenue Growth
13.50%Gross Profit (TTM)
116.75MCNY17.42M · vs all stocks (USD)
EBITDA (TTM)
54.66MCNY8.16M · vs all stocks (USD)
Net Income (TTM)
62.02MCNY9.25M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
81.20%Operating Cash Flow (TTM)
89.88MCNY13.41M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
74.61MCNY11.13M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.3000CNYUpdated Sep 20, 2026Trailing Annual Dividend Yield
2.15%vs all stocks
5-Year Average Dividend Yield
3.00%vs all stocks
Payout Ratio
76.92%Revenue
265.36MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
162.50MCNYFY2025 · Dec 31, 2025Gross Profit
102.86MCNYFY2025 · Dec 31, 2025Operating Income
48.36MCNY7.22M · vs all stocks (USD)
Pre-tax Income
63.43MCNYFY2025 · Dec 31, 2025Income Tax Expense
9.22MCNYFY2025 · Dec 31, 2025Net Income
54.21MCNYFY2025 · Dec 31, 2025EBIT
48.36MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
63.33MCNYFY2025 · Dec 31, 2025Research & Development
13.35MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
16.73MCNYFY2025 · Dec 31, 2025Other Operating Expenses
5.30MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
11.13MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.3400CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.3400CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
159.45MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
159.45MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
54.21MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
84.98MCNYFY2025 · Dec 31, 2025Free Cash Flow
81.54MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
311.84MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
54.21MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
4.93MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
25.84MCNYFY2025 · Dec 31, 2025Capital Expenditures
-3.45MCNYFY2025 · Dec 31, 2025Sale of Investments
5.94MCNYFY2025 · Dec 31, 2025Other Investing Activity
-215.00MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-212.50MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-48.00MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-48.00MCNYFY2025 · Dec 31, 2025Shares Outstanding
160.00MSharesUpdated Sep 20, 2026Float Shares
78.00MSharesUpdated Sep 20, 2026% Held by Insiders
53.81%vs all stocks
% Held by Institutions
2.60%vs all stocks
Total Cash (MRQ)
732.02MCNY109.23M · vs all stocks (USD)
Total Cash per Share (MRQ)
4.58CNYUpdated Sep 20, 2026Total Debt (MRQ)
0.00CNYvs all stocks (USD)
Total Debt to Equity (MRQ)
0.00xCurrent Ratio (MRQ)
16.76xBook Value per Share (MRQ)
5.18CNYUpdated Sep 20, 2026Total Assets
889.42MCNY132.72M · vs all stocks (USD)
Total Current Assets
767.34MCNYFY2025 · Dec 31, 2025Total Liabilities
52.60MCNYFY2025 · Dec 31, 2025Total Non-current Assets
122.08MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
7.90MCNYFY2025 · Dec 31, 2025Total Current Liabilities
44.71MCNYFY2025 · Dec 31, 2025Cash
310.25MCNYFY2025 · Dec 31, 2025Cash Equivalents
1.58MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
311.84MCNYFY2025 · Dec 31, 2025Other Short-term Investments
400.00MCNYFY2025 · Dec 31, 2025Accounts Receivable
10.42MCNYFY2025 · Dec 31, 2025Inventory
43.27MCNYFY2025 · Dec 31, 2025Accounts Payable
28.58MCNYFY2025 · Dec 31, 2025Other Current Liabilities
107.31KCNYFY2025 · Dec 31, 2025Common Stock (Book)
160.00MCNYFY2025 · Dec 31, 2025Retained Earnings
389.84MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
836.81MCNY124.87M · vs all stocks (USD)
52-Week Low
11.53CNYUpdated Sep 20, 202652-Week High
18.25CNYUpdated Sep 20, 202652-Week Change
-11.22%vs all stocks
Beta
0.3140xvs all stocks
50-Day MA
14.05CNYUpdated Sep 20, 2026200-Day MA
14.88CNYUpdated Sep 20, 2026Avg 10-Day Volume
2.15MSharesUpdated Sep 20, 2026Avg 30-Day Volume
4.79MSharesUpdated Sep 20, 2026Diluted EPS (TTM)
0.3900CNYUpdated Sep 20, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Shanxi C&Y Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang Shapuaisi Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Benitec Biopharma Inc.
Tier 1ProductionApproval-Gated PipelineRule
Cuorips Inc.
Tier 1ProductionApproval-Gated PipelineRule
Hubei Guangji Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Suzhou Fushilai Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineFlowRule
Bionote Inc.
Tier 1ProductionApproval-Gated PipelineRule
Newron Pharmaceuticals SpA
Tier 1ProductionApproval-Gated PipelineRuleRisk
Il Dong Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
BioAge Labs, Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking